FNDC3B, fibronectin type III domain containing 3B, 64778
N. diseases: 49; N. variants: 24
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Neoplasms; Skin and Connective Tissue Diseases | Neoplastic Process | 6941 | 3417 | 0.300 | None | 0 | ||||||||
|
phenotype | Organism Attribute | 1903 | 3972 | 0.100 | None | 1.000 | 8 | 7 | 2010 | 2019 | |||||
|
phenotype | Diagnostic Procedure | 206 | 573 | 0.100 | None | 1.000 | 6 | 6 | 2014 | 2018 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | Neoplastic Process | 6385 | 327 | 0.050 | None | 1.000 | 5 | 2009 | 2019 | |||||
|
phenotype | Neoplastic Process | 6626 | 169 | 0.050 | None | 1.000 | 5 | 2015 | 2019 | ||||||
|
phenotype | Organism Attribute | 565 | 1138 | 0.100 | None | 1.000 | 3 | 2 | 2018 | 2019 | |||||
|
phenotype | Laboratory Procedure | 593 | 988 | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | |||||
|
phenotype | Laboratory or Test Result | 593 | 988 | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | |||||
|
phenotype | Organism Attribute | 249 | 517 | 0.100 | None | 1.000 | 2 | 2 | 2010 | 2013 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | Neoplastic Process | 6243 | 355 | 0.020 | None | 1.000 | 2 | 2010 | 2019 | |||||
|
phenotype | Clinical Attribute | 36 | 103 | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||
|
phenotype | Behavior and Behavior Mechanisms | Individual Behavior | 391 | 765 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
phenotype | Laboratory Procedure | 234 | 474 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Diagnostic Procedure | 39 | 98 | 0.100 | None | 1.000 | 1 | 2 | 2013 | 2013 | |||||
|
phenotype | Finding | 653 | 1206 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Behavior and Behavior Mechanisms | Individual Behavior | 249 | 742 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
phenotype | Neoplastic Process | 1027 | 20 | 0.010 | None | 1.000 | 1 | 2016 | 2016 | ||||||
|
phenotype | Clinical Attribute | 35 | 61 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Laboratory Procedure | 160 | 355 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||
|
group | Neoplasms | Neoplastic Process | 8621 | 1641 | 0.050 | None | 1.000 | 5 | 2009 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 8221 | 1374 | 0.050 | None | 1.000 | 5 | 2009 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 10161 | 1644 | 0.020 | None | 1.000 | 2 | 2012 | 2017 | |||||
|
group | Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Congenital Abnormality | 1098 | 73 | 0.010 | None | 1.000 | 1 | 2016 | 2016 | |||||
|
group | Pathological Conditions, Signs and Symptoms; Neoplasms | Neoplastic Process | 2492 | 85 | 0.010 | None | 1.000 | 1 | 2009 | 2009 |